EICHOR
● Active Not Recruiting
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Condition: NASH - Nonalcoholic Steatohepatitis · Sponsor: Inventiva Pharma
About this study
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (459)
| Objective Health - Birmingham Gastroenterology Associates | Birmingham, Alabama, United States | — |
| Digestive Health Specialist of the Southeast | Dothan, Alabama, United States | — |
| North Alabama GI Research Center llc | Madison, Alabama, United States | — |
| The Institute For Liver Health - Chandler | Chandler, Arizona, United States | — |
| Arizona Liver Health - Peoria | Peoria, Arizona, United States | — |
| Dignity Health - St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Saint Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Adobe Gastroenterology | Tucson, Arizona, United States | — |
| Arizona Liver Health | Tucson, Arizona, United States | — |
| ARcare Center for Clinical Research - Conway | Conway, Arkansas, United States | — |
| ARcare Center for Clinical Research | Little Rock, Arkansas, United States | — |
| Arkansas Diagnostic Center | Little Rock, Arkansas, United States | — |
+ 447 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04849728